Comparison of a single vs. a four intradermal sterile water injection for relief of lower back pain for women in labour: A randomised controlled trial
Introduction
Almost one in three women in labour suffer from severe lower back pain (Melzack and Schaffeberg, 1987, Tzeng and Su, 2008). Clinicians often associate back pain with varying degrees of fetal malposition, particularly an occipito-posterior (OP) position (Simkin, 2010), as this is thought to cause pressure on pain-sensitive structures within the pelvis. Back pain in labour may also be referred pain (Ader et al., 1991). Characteristically, the pain persists throughout the normally painless resting intervals between contractions (Tzeng and Su, 2008). It may be associated with greater use of pharmacological analgesia, including epidural anaesthesia (Hutton et al., 2009) which is associated with a cascade of interventions and iatrogenic sequelae such as increased augmentation of labour, instrumental birth and urinary retention (Lieberman and O'Donoghue, 2002, Weiniger, 2006). Sterile water injections (SWI) administered into the lower back have been demonstrated to provide a suitable analgesic alternative with none of the aforementioned negative outcomes, hence their suitability for women wishing to avoid regional anaesthesia, or in localities where this service is not available (Hutton et al., 2009). The procedure is inexpensive, low technology, safe, and suitable for most maternity care settings (Hutton et al., 2009). The injection of sterile water causes somatic and mechanical irritation resulting in a brief (15–30 s), but significant, stinging sensation. Pain relief follows almost immediately and may last for up to 2 hrs; the procedure can be repeated a number of times (Martensson and Wallin, 2008). The physiology of the effect is thought to be related to the stimulation of ascending (gate control theory) (Melzack and Wall, 1965) and descending (diffuse noxious inhibitory controls; DNIC) (Le Bars et al., 1979) pain modulation systems. The most frequently used SWI technique consists of four intradermal injections into the skin surrounding the Michaelis rhomboid over the sacral area (Reynolds, 2000). Two clinicians, working in tandem, administer the injections concurrently.
All the blinded RCTs that have previously compared the four injection (FI) technique using sterile water against normal saline placebo controls demonstrated a statistically significant reduction in pain in favour of SWI (Ader and Hansson, 1990, Trolle and Moller, 1991, Martensson and Wallin, 1999, Wiruchpongsanon, 2006, Saxena and Nischal, 2009). However Derry et al. (2012) highlighted the need for SWI trials to report findings in a clinically relevant format. The intensity of the injection pain associated with the FI technique, may impact on the acceptability of the procedure to women (Fogarty, 2008, Martensson and Wallin, 2008). Hypothesising that one injection would result in less pain, two studies tested a single injection (SI) technique compared to a placebo and also reported a significant reduction in pain (Bahasadri and Ahmadi-Abhari, 2006, Kushtagi and Bhanu, 2009). Prior to our study no SI trial had been designed to compare the analgesic outcomes with the FI technique and hence it was not known if the two techniques provided similar levels of analgesia (Fogarty, 2008, Martensson and Wallin, 2008). The aim of this study was therefore to compare a single intradermal SWI with the four injection technique in both the degree and duration of analgesic effect. The results have significant implications for midwifery practice, and for women seeking alternatives to pharmacological interventions for the relief of back pain in labour.
Section snippets
Design and methods
A randomised, controlled, non-inferiority (NI) study was considered the most appropriate research design. Non-inferiority studies are particularly well suited to comparing an existing treatment with a new variation, and are becoming increasingly common in practice-based RCTs (Scott, 2009).
The study was conducted in two tertiary maternity hospitals in the same Australian city; ethics approval was granted at both sites. Women aged 18 years or over, with a term (37–42 weeks), singleton, cephalic
Recruitment
Recruitment occurred between January 2010 and February 2011; 352 women were eligible for inclusion over the study period. Of these, 44 declined participation and a further three were unable to participate for other reasons (Fig. 1). Thirty-two women who declined participation received SWI outside of the trial. A total of 305 women were thus randomised, 215 at Site One and 90 at Site Two.
Statistical methods
The primary outcome for this study was the difference between the groups in pre- and post-injection VAS scores measured at 30 mins. The non-inferiority margin of 1 cm was established, as this represents the minimum change in VAS required to indicate a significant difference in reported pain (Kelly, 2001). Visual analogue scale outcomes have also been reported as dichotomous outcomes for pain relief of at least 50% or 30% difference between pre- and post-injection self-reported pain scores at 10,
Results
Baseline characteristics were similar between treatment groups (Table 1), with some differences noted. For example, 24 women (16.4%) in the SI group received their antenatal and intrapartum care through a private obstetrician compared to 12 (7.6%) in the FI group. However, as this imbalance occurred by chance, and insurance status is unlikely to impact on the perception of pain and therefore the primary outcome, no adjustments in the analysis were considered necessary.
Data for the primary
Primary outcome
The mean difference in the pre- and post (30 mins)-injection scores between the SI and FI groups was −1.48 cm (95% CI −2.10, −0.86, p<0.001) in favour of the FI technique, indicating that, on average the FI provided a greater reduction in pain than the SI technique. The PP analysis demonstrated a difference of 1.51 cm (95% CI −2.13, −0.89, p<0.001). Both CI lower bounds are outside the clinically significant non-inferiority margin of 1 cm (Fig. 2), and therefore the SI technique cannot be
Other VAS outcomes
The median baseline VAS for back pain prior to injection was 8.0 (IQR: 7.0/9.0). Women in the SI group (n=142) rated the injection pain (median [IQR] 8.0 [7.0/9.0]) lower than women in the FI group (n=152) (median [IQR] 9.0 [8.0/10.0]) (p<0.001). The difference in the number of women experiencing 50% or more, or a 30% or more reduction in pain following injection was statistically significant up to 60 mins post-intervention. After 60 mins, more women in the FI group continued to report a
Analgesia and birth outcomes
There were no differences in the use of pharmacological analgesia subsequent to the administration of either technique. The relative risk (RR) for the final choice of pharmacological analgesia compared to no analgesic use is provided in Table 3.
There were no differences observed in mode of birth. The rates of normal vaginal birth (NVB) were 65.3% (n=96 SI) and 62.0% (n=98 FI). The RR for instrumental (ventouse or forceps) and caesarean section (CS) compared to NVB is provided in Table 4.
Repeat injections
Pre and 30 mins post-injection VAS scores were collected on 19 women who requested repeat injections; the FI technique was used in all cases. The median (IQR) pre-injection VAS score was 8.00 cm (6.75/10.00). The mean difference between pre-injection and thirty minutes post injection was 4.89 cm (SD 2.73). Although this cohort is small, the difference was statistically significant (p<0.001). Thirteen women (68%) reported a reduction in pain of 50% or more and 16 women (84%) reported a reduction in
Responses to the postnatal questionnaire
Two hundred and sixty-two women (85.0%) completed a questionnaire administered on the first postnatal day; distribution of respondents was similar between groups: SI (133; 90.0%) and FI groups (129; 82.0%). There was no difference in the number of women who reported being ‘very satisfied’ or ‘satisfied’ with either technique (SI 88, 66.2%; FI 97, 75.2%, p=0.142). Thirty-six women in the SI group (12.4%) compared with twenty-six women in the FI group (6.6%) responded that they were
Discussion
To our knowledge this is the first trial to compare the single and four SWI techniques. Our study makes a significant contribution to the small, but growing, body of evidence exploring the most effective technique for administering SWI. The results indicate that four injections administered concurrently provided a greater depth of analgesia than a single injection. The four injection technique achieved a 70% reduction in back pain. This is similar to reductions in pain levels (64–70%), between
Clinical implications
This study has demonstrated that SWI is effective in relieving back pain, with the FI technique being clinically more effective than the SI in providing significantly better analgesia at 30 mins post-injection. Repeat injections are effective in re-establishing analgesia. In some practice areas, particularly where only one care provider is available, the SI technique is a suitable alternative to FI. Similarly, if women wish to avoid the increased discomfort associated with four injections, and
Acknowledgements
We gratefully acknowledge the women and midwives who participated in the trial. We would also like to thank Peter Coxeter for assistance in the development of the trial protocol, Vanessa Wright for assistance with recruitment, Rebecca Cavallaro and Louise O’Beirne for their assistance with data collection. The postnatal questionnaire was adapted with permission from Dr K Peart. Funding for the study was provided by the John P. Kelly Research Foundation (Mater Health Services), The Queensland
References (34)
- et al.
Parturition pain treated by intracutaneous injections of sterile water
Pain
(1990) - et al.
The visual analogue pain intensity scale: what is moderate pain in millimetres
Pain
(1997) Intradermal sterile water injections for the relief of low back pain in labour—a systematic review of the literature
Women & Birth
(2008)- et al.
Unintended effects of epidural analgesia during labor: a systematic review
American Journal of Obstetrics and Gynecology
(2002) - et al.
Low-back pain during labour
American Journal of Obstetrics and Gynecology
(1987) - et al.
The effect of sterile water blocks on low back labor pain
American Journal of Obstetrics and Gynecology
(1991) - et al.
Injections of sterile water for labour pain
Nursing Times
(1991) - et al.
Subcutaneous sterile water injection for labour pain: a randomised controlled trial
Australian and New Zealand Journal of Obstetrics and Gynaecology
(2006) - Bergh, I.H., Stener-Victorin, E., Wallin, G., Martensson, L., 2009. Comparison of the PainMatcher and the Visual...
- et al.
Intracutaneous or subcutaneous sterile water injection compared with blinded controls for pain management in labour
Cochrane Database of Systematic Reviews.
(2012)
Sterile water injections for back pain in labour
New Zealand College of Midwives Journal
Sterile water injection for labour pain: a systematic review and meta-analysis of randomised controlled trials
BJOG: An International Journal of Obstetrics & Gynaecology
The minimum clinically significant difference in visual analogue scale pain score does not differ with severity of pain
Emergency Medicine Journal
Obstetric risk indicators for labour dystocia in nulliparous women: a multi-centre cohort study
BMC Pregnancy & Childbirth
Effectiveness of subcutaneous injection of sterile water to the lower back for pain relief in labor
Acta Obstetricia et Gynecologica Scandinavica
A randomized controlled trial of nonpharmacologic approaches for relief of low back pain during labor
Journal of Family Practice
Diffuse noxious inhibitory controls (DNIC). II. Lack of effect on non-convergent neurones, supraspinal involvement and theoretical implications
Pain
Cited by (23)
Beyond the epidural: Alternatives to neuraxial labor analgesia
2022, Best Practice and Research: Clinical AnaesthesiologyMidwives and women's experiences of Sterile Water Injections for back pain during labour: An integrative review
2021, MidwiferyCitation Excerpt :Women's reasons for choosing SWI's included wanting to use a non-pharmacological pain relief method. The desire to be in control of their pain, the degree of analgesia and the onset of the pain relief were important for women using SWI's during labour (Lee et al., 2013b, 2017b). Many of the women in Lee et al.’s (2017b) study indicated that they had no expectations of gaining relief from using SWI's and therefore the analgesia resulting from this procedure was less likely to be a placebo effect.
Reply to correspondence: Intradermal sterile water injection for acute renal colic pain. MS 23569R1
2021, American Journal of Emergency Medicine